glp 1 neurotransmitter GLP-1 Analogues in the Neurobiology of Addiction: Translational Insights and Therapeutic Perspectives Further support for GLP-1R agonists

Oncotarget (2017)

For example, ketogenic diets might delay the need for medication since ketones naturally help curb appetite

Krishnan A, Hadi Y, Hutson WR, Thakkar S, Singh S

Competitive Landscape GLP-1 Weight Loss Drug Market Competitive Landscape: Novo Nordisk and Eli Lilly Duopoly, Oral GLP-1 Challengers, and Telehealth Platforms Reshape the Obesity Drug Market Through 2035 The GLP-1 Weight Loss Drug Market competitive landscape is defined by exceptional concentration at the approved drug tier where Novo Nordisk and Eli Lilly collectively control approximately 87% of global prescription obesity drug revenue combined with intense clinical development competition among more than 40 active GLP-1 pipeline programs

Kuznetsova, A., Brockhoff, P

Does injection site affect side effects like nausea